Summer 2024
By Colleen Sullivan
CURE Childhood Cancer awarded $330,000 to support research led by Yana Pikman, MD, as she tests a new combination therapy for leukemia with RAS signaling pathway mutations. This new therapy could provide a better, more durable treatment option for pediatric patients, especially those with relapsed leukemia who have developed resistance to current methods.